Sentry Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-60,200
Closed -$8.41M 212
2017
Q4
$8.41M Sell
60,200
-2,400
-4% -$334K 0.11% 117
2017
Q3
$8.14M Sell
62,600
-23,700
-27% -$3.14M 0.08% 117
2017
Q2
$11.4M Buy
+86,300
New +$11M 0.08% 108
2017
Q1
Sell
-46,600
Closed -$5.37M 155
2016
Q4
$5.37M Hold
46,600
0.04% 132
2016
Q3
$5.5K Sell
46,600
-8,000
-15% -$971K 0.05% 121
2016
Q2
$6.62K Sell
54,600
-55,000
-50% -$6.25M 0.06% 110
2016
Q1
$11.9K Hold
109,600
0.14% 92
2015
Q4
$11.3K Hold
109,600
0.13% 102
2015
Q3
$10.2K Buy
109,600
+87,600
+398% +$8.47M 0.12% 106
2015
Q2
$2.14K Buy
+22,000
New +$2.2M 0.03% 140

Other funds holding JNJ

Sentry Investments's JNJ Position: Q1 2018 in Review

Sentry Investments sold out of Johnson & Johnson (JNJ) in Q1 2018, closing a stake of 60,200 shares — an estimated $8.41M sold.

Sentry Investments first reported a position in JNJ in Q2 2015 and held it in 10 quarters. The position peaked at $11.4M in Q2 2017. 2,597 funds tracked by Wall St. Rank hold JNJ as of Q1 2018.

  • Sentry Investments reported no remaining Johnson & Johnson position as of Q1 2018 after selling out during the quarter.
  • Sentry Investments sold 60,200 Johnson & Johnson shares in Q1 2018, an estimated $8.41M.
  • Sentry Investments first reported a position in Johnson & Johnson in Q2 2015 and held it in 10 quarters.
  • Sentry Investments's Johnson & Johnson position peaked at $11.4M in Q2 2017.
  • 2,597 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2018.

Based on Sentry Investments's 13F filing for Q1 2018, filed 11 May 2018.